M1 Kliniken AG
XETRA:M12
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M1 Kliniken AG
XETRA:M12
|
DE |
|
Civeo Corp
NYSE:CVEO
|
US |
|
R
|
Royal Deluxe Holdings Ltd
HKEX:3789
|
HK |
|
Changzhou NRB Corp
SZSE:002708
|
CN |
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
IL |
|
Amara Raja Energy & Mobility Ltd
BSE:500008
|
IN |
|
I
|
International Care Company SpA
MIL:ICC
|
IT |
|
A
|
AXP Energy Ltd
OTC:AUNXF
|
US |
|
F
|
Flair Writing Industries Ltd
NSE:FLAIR
|
IN |
|
H
|
Haier Smart Home Co Ltd
HKEX:6690
|
CN |
|
N
|
NVIDIA Corp
XETRA:NVD
|
US |
|
Manawa Energy Ltd
NZX:MNW
|
NZ |
|
S
|
Siemens Gamesa Renewable Energy SA
XETRA:GTQ1
|
ES |
|
J
|
Jaiprakash Power Ventures Ltd
BSE:532627
|
IN |
|
Nanjing Xinlian Electronics Co Ltd
SZSE:002546
|
CN |
|
CRH PLC
LSE:CRH
|
IE |
Balance Sheet
Balance Sheet Decomposition
M1 Kliniken AG
M1 Kliniken AG
Balance Sheet
M1 Kliniken AG
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
1
|
2
|
0
|
6
|
15
|
25
|
9
|
22
|
38
|
35
|
22
|
21
|
|
| Cash |
1
|
2
|
0
|
6
|
15
|
25
|
9
|
22
|
38
|
35
|
22
|
21
|
|
| Short-Term Investments |
1
|
2
|
0
|
3
|
1
|
1
|
23
|
32
|
18
|
17
|
4
|
3
|
|
| Total Receivables |
0
|
2
|
16
|
7
|
9
|
17
|
25
|
24
|
18
|
24
|
32
|
20
|
|
| Accounts Receivables |
0
|
2
|
16
|
7
|
9
|
17
|
22
|
20
|
16
|
22
|
28
|
16
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
2
|
2
|
4
|
3
|
|
| Inventory |
0
|
1
|
3
|
1
|
1
|
1
|
2
|
42
|
35
|
28
|
46
|
37
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
2
|
1
|
3
|
7
|
3
|
|
| Total Current Assets |
2
|
8
|
20
|
17
|
30
|
45
|
59
|
122
|
110
|
107
|
111
|
84
|
|
| PP&E Net |
1
|
1
|
0
|
1
|
4
|
5
|
16
|
16
|
15
|
17
|
14
|
13
|
|
| PP&E Gross |
0
|
1
|
0
|
1
|
4
|
5
|
16
|
16
|
15
|
17
|
14
|
13
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
4
|
13
|
17
|
19
|
22
|
25
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
26
|
26
|
25
|
25
|
|
| Goodwill |
14
|
14
|
8
|
8
|
8
|
8
|
8
|
34
|
34
|
34
|
62
|
62
|
|
| Long-Term Investments |
6
|
16
|
5
|
6
|
9
|
11
|
9
|
12
|
12
|
12
|
1
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
14
|
14
|
8
|
8
|
8
|
8
|
8
|
34
|
34
|
34
|
62
|
62
|
|
| Total Assets |
22
N/A
|
39
+73%
|
33
-14%
|
32
-3%
|
51
+57%
|
70
+38%
|
93
+33%
|
189
+103%
|
198
+5%
|
197
-1%
|
213
+8%
|
188
-12%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
3
|
1
|
1
|
1
|
8
|
16
|
13
|
19
|
33
|
13
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
7
|
1
|
0
|
0
|
0
|
0
|
2
|
26
|
18
|
6
|
7
|
14
|
|
| Other Current Liabilities |
0
|
8
|
0
|
1
|
2
|
5
|
4
|
17
|
12
|
12
|
18
|
17
|
|
| Total Current Liabilities |
7
|
10
|
3
|
2
|
3
|
6
|
14
|
58
|
43
|
37
|
58
|
44
|
|
| Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
9
|
14
|
13
|
13
|
10
|
7
|
|
| Deferred Income Tax |
0
|
2
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
2
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
45
|
49
|
30
|
28
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
7
N/A
|
13
+83%
|
3
-74%
|
2
-44%
|
3
+70%
|
6
+77%
|
25
+323%
|
103
+319%
|
103
+0%
|
103
+0%
|
100
-4%
|
82
-18%
|
|
| Equity | |||||||||||||
| Common Stock |
15
|
15
|
15
|
15
|
17
|
18
|
18
|
20
|
20
|
20
|
20
|
20
|
|
| Retained Earnings |
6
|
10
|
15
|
15
|
31
|
46
|
51
|
67
|
77
|
75
|
94
|
88
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Equity |
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
15
N/A
|
25
+68%
|
30
+17%
|
30
+2%
|
47
+56%
|
64
+35%
|
68
+7%
|
86
+26%
|
95
+11%
|
94
-1%
|
113
+21%
|
106
-6%
|
|
| Total Liabilities & Equity |
22
N/A
|
39
+73%
|
33
-14%
|
32
-3%
|
51
+57%
|
70
+38%
|
93
+33%
|
189
+103%
|
198
+5%
|
197
-1%
|
213
+8%
|
188
-12%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
15
|
15
|
15
|
15
|
17
|
18
|
18
|
20
|
20
|
18
|
19
|
19
|
|